Scotland’s National Health Service will routinely fund BMS' Opdivo in combination with Yervoy for advanced melanoma, as part of a group of decisions by the cost-effectiveness body. The decision ...

Bristol-Myers Squibb’s cancer immunotherapy Opdivo is likely to gain another use in Europe after regulators recommended it after surgery for skin cancer ... resection. BMS is competing against ...